Is collagen XV a tumor suppressor?

DNA and Cell Biology

Volumn 22, Issue 4, 2003, Pages 225-226

  Harris, Henry ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 15; PROCOLLAGEN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENICITY; CARCINOMA; CELL DIFFERENTIATION; CELL FUSION; CHROMOSOME 4; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CYTOGENETICS; DIPLOIDY; EXTRACELLULAR MATRIX; GENE MAPPING; GENETIC ANALYSIS; GENETIC COMPATIBILITY; GLYCOSYLATION; HYBRID CELL; IN VIVO STUDY; LYMPHOMA; MELANOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SARCOMA; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

ANIMALS; CELL ADHESION; COLLAGEN; GENES, TUMOR SUPPRESSOR; HUMANS; HYBRID CELLS; MICE;

EID: 0037865389     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454903321908601     Document Type: Article

References (15)

1. EKLUND, L., PIUHOLA, J., KOMULAINEN, J., SORMUNEN, R., ONGVARRASOPONE, C., FÄSSLER, R., MUONA, A., ILVES, M., RUSKOAHO, H., TAKALA, T.E.S., et al. (2001a). Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc. Natl Acad. Sci. USA, 98, 1194-1199.
2. EKLUND, L.K., ISLAM, K., SODERKVIST, P., and ISLAM, M.Q. (2001b). Regional mapping of suppressor loci for anchorage independence and tumorigenicity on human chromosome 9. Cancer Genet. Cytogenet. 130, 118-126.
3. EVANS, E.P., BURTENSHAW, M.D., BROWN, B.B., HENNION, R., and HARRIS, H. (1982). The analysis of malignancy. IX. Re-examination and clarification of the cytogenetic problem. J. Cell Sci. 56, 113-130.
4. GREGORY, S.G., et al. (2002). A physical map of the mouse genome. Nature published on line 4 August.
5. HAGG, P.M., HAGG, P.O., PELTONEN, S., AUTIO-HARMAINEN, H., and PIHLAJANIEMI, T. (1997a). Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. Am. J. Pathol. 150, 2075-2086.
6. HAGG, P.M., HORELLI-HUITUNEN, N., EKLUND, L., PALOTIE, A., and PIHLAJANIEMI, T. (1997b). Cloning of mouse type XV collagen sequences and mapping of the corresponding gene to 4B1-3. Genomics, 45, 31-41.
7. HARRIS, H. (1971). Cell fusion and the analysis of malignancy. The Croonian Lecture. Proc. R. Soc. Lond. B. 179, 1-20.
8. HARRIS, H. (1985). Suppression of malignancy in hybrid cells: The mechanism. J. Cell Sci. 79, 83-94.
9. HARRIS, H., MILLER, O.J., KLEIN, G., WORST, P., and TACHIBANA, T. (1969). Suppression of malignancy by cell fusion. Nature 223, 363-368.
10. JONASSON, J., POVEY, S., and HARRIS, H. (1977). The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J. Cell Sci. 24, 217-254.
11. KIVIRIKKO, S., HEINÄMÄKI, P., REHN, M., HONKANEN, N., MYERS, J.C., and PIHLAJANIEMI, T. (1994). Primary structure of the a1 chain of human type XV collagen. J. Biol. Chem. 269, 4773-4779.
12. LI, D., CLARK, C.C., and MYERS, J.C. (2000). Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J. Biol. Chem. 275, 22339-22347.
13. MYERS, J.C., DION, A.S., ABRAHAM, V., and AMENTA, P.S. (1996). Type XV collagen exhibits a widespread distribution in human tissues but a distinct localisation in basement membrane zones. Cell Tissue Res. 286, 493-505.
14. MYERS, J.C., KIVIRIKKO, S., GORDON, M.K., DION, A.S., and PIHLAJANIEMI, T. (1992). Identification of a previously unknown human collagen chain, a1 (XV), characterised by extensive interruptions in the triple-helical region. Proc. Natl. Acad. Sci. USA 89, 10144-10148.
15. REHN, M., HINTIKKA, E., and PIHLAJANIEMI, T. (1994). Primary structure of the a1 chain of mouse type XVIII collagen. J. Biol. Chem. 269, 13929-13935.